{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:44:53Z","timestamp":1793148293696,"version":"4.5.0"},"reference-count":198,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.yjmcc.2023.12.009","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T02:11:41Z","timestamp":1705716701000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"special_numbering":"C","title":["Stem cell-based therapy in cardiac repair after myocardial infarction: Promise, challenges, and future directions"],"prefix":"10.1016","volume":"188","author":[{"given":"Wenjun","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huishou","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinliang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.yjmcc.2023.12.009_bb0005","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/mt.2015.167","article-title":"Cardiac nerve growth factor overexpression induces bone marrow-derived progenitor cells mobilization and homing to the infarcted heart","volume":"23","author":"Meloni","year":"2015","journal-title":"Mol. Ther."},{"issue":"22","key":"10.1016\/j.yjmcc.2023.12.009_bb0010","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1161\/CIRCULATIONAHA.117.029557","article-title":"C1q\/tumor necrosis factor-related Protein-9 regulates the fate of implanted mesenchymal stem cells and mobilizes their protective effects against ischemic heart injury via multiple novel signaling pathways","volume":"136","author":"Yan","year":"2017","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.yjmcc.2023.12.009_bb0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/ars.2018.7688","article-title":"Human embryonic stem cell-derived cardiovascular progenitors repair infarcted hearts through modulation of macrophages via activation of signal transducer and activator of transcription 6","volume":"31","author":"Wang","year":"2019","journal-title":"Antioxid. Redox Signal."},{"issue":"7","key":"10.1016\/j.yjmcc.2023.12.009_bb0020","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt.4162","article-title":"Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates","volume":"36","author":"Liu","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.009_bb0025","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/CIRCULATIONAHA.120.049497","article-title":"Cyclin D2 overexpression enhances the efficacy of human induced pluripotent stem cell-derived cardiomyocytes for myocardial repair in a swine model of myocardial infarction","volume":"144","author":"Zhao","year":"2021","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.009_bb0030","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/cvr\/cvab135","article-title":"Cell therapy in patients with heart failure: a comprehensive review and emerging concepts","volume":"118","author":"Bolli","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0035","article-title":"Mesenchymal stromal cells for improvement of cardiac function following acute myocardial infarction: a matter of timing","author":"Barr\u00e8re-Lemaire","year":"2023","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.009_bb0040","first-page":"393","article-title":"The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells","volume":"3","author":"Friedenstein","year":"1970","journal-title":"Cell Tissue Kinet."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.009_bb0045","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.009_bb0050","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013784","article-title":"Tailorable hydrogel improves retention and cardioprotection of intramyocardial transplanted mesenchymal stem cells for the treatment of acute myocardial infarction in mice","volume":"9","author":"Chen","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"7","key":"10.1016\/j.yjmcc.2023.12.009_bb0055","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/CIRCRESAHA.119.315806","article-title":"N-cadherin overexpression mobilizes the protective effects of mesenchymal stromal cells against ischemic heart injury through a \u03b2-catenin-dependent manner","volume":"126","author":"Yan","year":"2020","journal-title":"Circ. Res."},{"issue":"24","key":"10.1016\/j.yjmcc.2023.12.009_bb0060","first-page":"e2200431","article-title":"Mesenchymal stromal cells overexpressing farnesoid X receptor exert cardioprotective effects against acute ischemic heart injury by binding endogenous bile acids","volume":"vol. 9","author":"Xia","year":"2022","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"7","key":"10.1016\/j.yjmcc.2023.12.009_bb0065","first-page":"e2103697","article-title":"Irisin promotes cardiac homing of intravenously delivered MSCs and protects against ischemic heart injury","volume":"vol. 9","author":"Yan","year":"2022","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0070","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.biomaterials.2016.11.029","article-title":"Safety and efficacy of cardiopoietic stem cells in the treatment of post-infarction left-ventricular dysfunction - from cardioprotection to functional repair in a translational pig infarction model","volume":"122","author":"Emmert","year":"2017","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.yjmcc.2023.12.009_bb0075","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/CIRCRESAHA.117.311174","article-title":"Cortical bone stem cell therapy preserves cardiac structure and function after myocardial infarction","volume":"121","author":"Sharp","year":"2017","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.12.009_bb0080","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.5966\/sctm.2015-0298","article-title":"Human umbilical cord-derived mesenchymal stromal cells improve left ventricular function","volume":"5","author":"Liu","year":"2016","journal-title":"Stem Cells Transl. Med."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.12.009_bb0085","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1161\/CIRCINTERVENTIONS.114.001580","article-title":"Intracoronary infusion of encapsulated glucagon-like peptide-1-eluting mesenchymal stem cells preserves left ventricular function in a porcine model of acute myocardial infarction","volume":"7","author":"de Jong","year":"2014","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"6","key":"10.1016\/j.yjmcc.2023.12.009_bb0090","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/CIRCRESAHA.115.307516","article-title":"A large-scale investigation of hypoxia-preconditioned allogeneic mesenchymal stem cells for myocardial repair in nonhuman primates: paracrine activity without remuscularization","volume":"118","author":"Hu","year":"2016","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.009_bb0095","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s00395-020-0800-8","article-title":"Intravenously delivered mesenchymal stem cells prevent microvascular obstruction formation after myocardial ischemia\/reperfusion injury","volume":"115","author":"Wang","year":"2020","journal-title":"Basic Res. Cardiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.009_bb0100","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"5858","key":"10.1016\/j.yjmcc.2023.12.009_bb0105","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"vol. 318","author":"Yu","year":"2007","journal-title":"Science (New York, N.Y.)"},{"issue":"7625","key":"10.1016\/j.yjmcc.2023.12.009_bb0110","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nature19815","article-title":"Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts","volume":"538","author":"Shiba","year":"2016","journal-title":"Nature"},{"issue":"363","key":"10.1016\/j.yjmcc.2023.12.009_bb0115","doi-asserted-by":"crossref","first-page":"363ra148","DOI":"10.1126\/scitranslmed.aaf8781","article-title":"Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells","volume":"8","author":"Weinberger","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"16","key":"10.1016\/j.yjmcc.2023.12.009_bb0120","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/CIRCULATIONAHA.117.030785","article-title":"Large cardiac muscle patches engineered from human induced-pluripotent stem cell-derived cardiac cells improve recovery from myocardial infarction in swine","volume":"137","author":"Gao","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.009_bb0125","first-page":"239","article-title":"Intramyocardial transplantation of human iPS cell-derived cardiac spheroids improves cardiac function in heart failure animals, JACC","volume":"6","author":"Kawaguchi","year":"2021","journal-title":"Basic Transl. Sci."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0130","first-page":"74","article-title":"Heart regeneration with human pluripotent stem cells: prospects and challenges","volume":"5","author":"Jiang","year":"2020","journal-title":"Bioact. Mater."},{"issue":"30","key":"10.1016\/j.yjmcc.2023.12.009_bb0135","doi-asserted-by":"crossref","first-page":"E6072","DOI":"10.1073\/pnas.1702295114","article-title":"Functional characterization of human pluripotent stem cell-derived arterial endothelial cells","volume":"114","author":"Zhang","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"27","key":"10.1016\/j.yjmcc.2023.12.009_bb0140","first-page":"e2300470","article-title":"hESC-Derived epicardial cells promote repair of infarcted hearts in mouse and swine","volume":"vol. 10","author":"Luo","year":"2023","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.009_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/cells10040792","article-title":"Human-induced pluripotent stem-cell-derived smooth muscle cells increase angiogenesis to treat Hindlimb ischemia","volume":"10","author":"Gao","year":"2021","journal-title":"Cells"},{"issue":"13","key":"10.1016\/j.yjmcc.2023.12.009_bb0150","doi-asserted-by":"crossref","first-page":"eaay6994","DOI":"10.1126\/sciadv.aay6994","article-title":"In vivo priming of human mesenchymal stem cells with hepatocyte growth factor-engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair","volume":"6","author":"Park","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101929","article-title":"Identification of a CTRP9 C-terminal polypeptide capable of enhancing bone-derived mesenchymal stem cell cardioprotection through promoting angiogenic exosome production","volume":"41","author":"Liu","year":"2021","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13287-019-1544-y","article-title":"IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway","volume":"11","author":"Lin","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0165","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13287-020-01648-0","article-title":"Mending a broken heart: current strategies and limitations of cell-based therapy","volume":"11","author":"Liew","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"22","key":"10.1016\/j.yjmcc.2023.12.009_bb0170","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.7150\/thno.28021","article-title":"Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction","volume":"8","author":"Zhu","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112118","article-title":"Mesenchymal stem cell-derived exosome microRNA as therapy for cardiac ischemic injury","volume":"143","author":"Nasser","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.yjmcc.2023.12.009_bb0180","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/cvr\/cvz040","article-title":"Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization","volume":"115","author":"Zhao","year":"2019","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.009_bb0185","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7150\/thno.73568","article-title":"Therapeutic delivery of microRNA-125a-5p oligonucleotides improves recovery from myocardial ischemia\/reperfusion injury in mice and swine","volume":"13","author":"Gao","year":"2023","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.yjmcc.2023.12.009_bb0190","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","article-title":"Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential","volume":"41","author":"Song","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.yjmcc.2023.12.009_bb0195","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.117.310599","article-title":"Intravenously delivered mesenchymal stem cells: systemic anti-inflammatory effects improve left ventricular dysfunction in acute myocardial infarction and ischemic cardiomyopathy","volume":"120","author":"Luger","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0200","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3389\/fimmu.2020.00639","article-title":"Healing the broken heart; The immunomodulatory effects of stem cell therapy","volume":"11","author":"Wagner","year":"2020","journal-title":"Front. Immunol."},{"issue":"7790","key":"10.1016\/j.yjmcc.2023.12.009_bb0205","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-019-1802-2","article-title":"An acute immune response underlies the benefit of cardiac stem cell therapy","volume":"577","author":"Vagnozzi","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.009_bb0210","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ymthe.2020.01.011","article-title":"Cardiac nestin(+) mesenchymal stromal cells enhance healing of ischemic heart through Periostin-mediated M2 macrophage polarization","volume":"28","author":"Liao","year":"2020","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.yjmcc.2023.12.009_bb0215","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/stem.2369","article-title":"Mesenchymal stromal cells induce peculiar alternatively activated macrophages capable of dampening both innate and adaptive immune responses","volume":"34","author":"Chiossone","year":"2016","journal-title":"Stem Cells (Dayton, Ohio)"},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.009_bb0220","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.7150\/thno.46119","article-title":"Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction","volume":"11","author":"Sun","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0225","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-bioeng-070909-105309","article-title":"Mesenchymal stem cells as therapeutics","volume":"12","author":"Parekkadan","year":"2010","journal-title":"Annu. Rev. Biomed. Eng."},{"issue":"26","key":"10.1016\/j.yjmcc.2023.12.009_bb0230","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.1182\/blood-2009-02-203943","article-title":"MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2","volume":"113","author":"Spaggiari","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.yjmcc.2023.12.009_bb0235","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/stem.3185","article-title":"Mesenchymal stromal cells induce regulatory T cells via epigenetic conversion of human conventional CD4 T cells in vitro","volume":"38","author":"Azevedo","year":"2020","journal-title":"Stem Cells (Dayton, Ohio)"},{"issue":"10","key":"10.1016\/j.yjmcc.2023.12.009_bb0240","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1161\/CIRCRESAHA.122.321384","article-title":"Intrapericardial exosome therapy dampens cardiac injury via activating Foxo3","volume":"131","author":"Zhu","year":"2022","journal-title":"Circ. Res."},{"issue":"5923","key":"10.1016\/j.yjmcc.2023.12.009_bb0245","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1164680","article-title":"Evidence for cardiomyocyte renewal in humans","volume":"vol. 324","author":"Bergmann","year":"2009","journal-title":"Science (New York, N.Y.)"},{"issue":"15","key":"10.1016\/j.yjmcc.2023.12.009_bb0250","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/CIRCULATIONAHA.122.060124","article-title":"Contractile force of transplanted cardiomyocytes actively supports heart function after injury","volume":"146","author":"St\u00fcdemann","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0255","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.healun.2023.08.011","article-title":"Pleiotropic effects of extracellular vesicles from induced pluripotent stem cell-derived cardiomyocytes on ischemic cardiomyopathy: a preclinical study","volume":"43","author":"Tominaga","year":"2024","journal-title":"J. Heart Lung Transpl."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.12.009_bb0260","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jacc.2020.12.060","article-title":"Mitochondria-rich extracellular vesicles from autologous stem cell-derived cardiomyocytes restore energetics of ischemic myocardium","volume":"77","author":"Ikeda","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2023.12.009_bb0265","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1161\/CIRCRESAHA.117.310803","article-title":"Paracrine effects of the pluripotent stem cell-derived cardiac myocytes salvage the injured myocardium","volume":"121","author":"Tachibana","year":"2017","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0270","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ymthe.2022.08.012","article-title":"Transient secretion of VEGF protein from transplanted hiPSC-CMs enhances engraftment and improves rat heart function post MI","volume":"31","author":"Ai","year":"2023","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.009_bb0275","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.3390\/cimb45030150","article-title":"Effect of atorvastatin on angiogenesis-related genes VEGF-A, HGF and IGF-1 and the modulation of PI3K\/AKT\/mTOR transcripts in bone-marrow-derived mesenchymal stem cells","volume":"45","author":"Adami\u010dkov\u00e1","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0280","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3892\/ijmm.2015.2413","article-title":"Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue","volume":"37","author":"Heo","year":"2016","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.009_bb0285","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaccao.2021.05.006","article-title":"Mitochondria-rich extracellular vesicles rescue patient-specific cardiomyocytes from doxorubicin injury: insights into the SENECA trial, JACC","volume":"3","author":"O\u2019Brien","year":"2021","journal-title":"CardioOncology"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0290","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1186\/s13287-020-02032-8","article-title":"Comprehensive proteomic analysis of exosomes derived from human bone marrow, adipose tissue, and umbilical cord mesenchymal stem cells","volume":"11","author":"Wang","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"10.1016\/j.yjmcc.2023.12.009_bb0295","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/CIRCRESAHA.118.312758","article-title":"Transplanted mesenchymal stem cells reduce autophagic flux in infarcted hearts via the exosomal transfer of miR-125b","volume":"123","author":"Xiao","year":"2018","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0300","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13287-020-1563-8","article-title":"Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN\/AKT pathway","volume":"11","author":"Wen","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0305","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13287-020-01746-z","article-title":"FNDC5\/irisin improves the therapeutic efficacy of bone marrow-derived mesenchymal stem cells for myocardial infarction","volume":"11","author":"Deng","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0310","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.imlet.2020.05.005","article-title":"Changes of immune parameters of T lymphocytes and macrophages in EAE mice after BM-MSCs transplantation","volume":"225","author":"Xin","year":"2020","journal-title":"Immunol. Lett."},{"issue":"21","key":"10.1016\/j.yjmcc.2023.12.009_bb0315","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1089\/scd.2013.0166","article-title":"Bone marrow-derived mesenchymal stem cells favor the immunosuppressive T cells skewing in a helicobacter pylori model of gastric cancer","volume":"22","author":"Lin","year":"2013","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0320","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.imlet.2017.09.010","article-title":"BM-MSCs-derived microvesicles promote allogeneic kidney graft survival through enhancing micro-146a expression of dendritic cells","volume":"191","author":"Wu","year":"2017","journal-title":"Immunol. Lett."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.009_bb0325","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/stem.2759","article-title":"Graft-versus-host disease amelioration by human bone marrow mesenchymal stromal\/stem cell-derived extracellular vesicles is associated with peripheral preservation of naive T cell populations","volume":"36","author":"Fujii","year":"2018","journal-title":"Stem Cells (Dayton, Ohio)"},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.009_bb0330","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ymthe.2017.09.023","article-title":"Stem cell secretome and its effect on cellular mechanisms relevant to wound healing","volume":"26","author":"Park","year":"2018","journal-title":"Mol. Therapy"},{"issue":"5","key":"10.1016\/j.yjmcc.2023.12.009_bb0335","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s10753-021-01460-9","article-title":"Adipose-derived mesenchymal stem cells-derived exosomes carry MicroRNA-671 to alleviate myocardial infarction through inactivating the TGFBR2\/Smad2 Axis","volume":"44","author":"Wang","year":"2021","journal-title":"Inflammation"},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.009_bb0340","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2337\/db17-0356","article-title":"Exosomes from adipose-derived stem cells attenuate adipose inflammation and obesity through polarizing M2 macrophages and Beiging in White adipose tissue","volume":"67","author":"Zhao","year":"2018","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0345","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s13287-022-03037-1","article-title":"Exosomal miR-17-5p from adipose-derived mesenchymal stem cells inhibits abdominal aortic aneurysm by suppressing TXNIP-NLRP3 inflammasome","volume":"13","author":"Hu","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"10.1016\/j.yjmcc.2023.12.009_bb0350","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.7150\/thno.52677","article-title":"Conditioned medium from adipose-derived stem cells attenuates ischemia\/reperfusion-induced cardiac injury through the microRNA-221\/222\/PUMA\/ETS-1 pathway","volume":"11","author":"Lee","year":"2021","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.yjmcc.2023.12.009_bb0355","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.7150\/thno.81336","article-title":"CSF2RB overexpression promotes the protective effects of mesenchymal stromal cells against ischemic heart injury","volume":"13","author":"Qi","year":"2023","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.009_bb0360","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.yexcr.2018.07.037","article-title":"The suppression effect of dendritic cells maturation by adipose-derived stem cells through TGF-\u03b21 related pathway","volume":"370","author":"Wang","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0365","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3389\/fimmu.2015.00560","article-title":"Comparing the immunomodulatory properties of bone marrow, adipose tissue, and birth-associated tissue mesenchymal stromal cells","volume":"6","author":"Mattar","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0370","doi-asserted-by":"crossref","first-page":"1128359","DOI":"10.3389\/fimmu.2023.1128359","article-title":"Umbilical cord-mesenchymal stem cells induce a memory phenotype in CD4(+) T cells","volume":"14","author":"Sengun","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0375","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fimmu.2019.00018","article-title":"The Secretome derived from 3D-cultured umbilical cord tissue MSCs counteracts manifestations typifying rheumatoid arthritis","volume":"10","author":"Miranda","year":"2019","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.yjmcc.2023.12.009_bb0380","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202300317RRR","article-title":"Exosomal circBBS2 inhibits ferroptosis by targeting miR-494 to activate SLC7A11 signaling in ischemic stroke","volume":"37","author":"Hong","year":"2023","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0385","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13287-018-0888-z","article-title":"Intravenous injection of allogeneic umbilical cord-derived multipotent mesenchymal stromal cells reduces the infarct area and ameliorates cardiac function in a porcine model of acute myocardial infarction","volume":"9","author":"Lim","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174994","article-title":"Human umbilical cord-derived stem cell sheets improve left ventricular function in rat models of ischemic heart failure","volume":"925","author":"Wu","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.12.009_bb0395","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/art.38674","article-title":"A CD8 T cell\/indoleamine 2,3-dioxygenase axis is required for mesenchymal stem cell suppression of human systemic lupus erythematosus","volume":"vol. 66","author":"Wang","year":"2014","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0400","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biomaterials.2012.09.042","article-title":"Improvement of ventilator-induced lung injury by IPS cell-derived conditioned medium via inhibition of PI3K\/Akt pathway and IP-10-dependent paracrine regulation","volume":"34","author":"Li","year":"2013","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.yjmcc.2023.12.009_bb0405","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.89","article-title":"Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in \u03b2-adrenergic signaling and enhances apoptosis","volume":"6","author":"Roca-Alonso","year":"2015","journal-title":"Cell Death Dis."},{"issue":"561","key":"10.1016\/j.yjmcc.2023.12.009_bb0410","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1318","article-title":"Exosomes secreted by hiPSC-derived cardiac cells improve recovery from myocardial infarction in swine","volume":"12","author":"Gao","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.12.009_bb0415","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1161\/CIRCULATIONAHA.114.015231","article-title":"Microfluidic single-cell analysis of transplanted human induced pluripotent stem cell-derived cardiomyocytes after acute myocardial infarction","volume":"132","author":"Ong","year":"2015","journal-title":"Circulation"},{"issue":"11 Suppl 1","key":"10.1016\/j.yjmcc.2023.12.009_bb0420","first-page":"S29","article-title":"Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model","volume":"126","author":"Kawamura","year":"2012","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.009_bb0425","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","article-title":"Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility","volume":"24","author":"Xu","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"21","key":"10.1016\/j.yjmcc.2023.12.009_bb0430","doi-asserted-by":"crossref","first-page":"10441","DOI":"10.1073\/pnas.1902566116","article-title":"Generation of hypoimmunogenic human pluripotent stem cells","volume":"116","author":"Han","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.009_bb0435","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180563","article-title":"Induced pluripotent stem cell-derived endothelial cells promote angiogenesis and accelerate wound closure in a murine excisional wound healing model","volume":"38","author":"Clayton","year":"2018","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0440","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13287-023-03462-w","article-title":"Exosomes secreted by endothelial cells derived from human induced pluripotent stem cells improve recovery from myocardial infarction in mice","volume":"14","author":"Li","year":"2023","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0445","doi-asserted-by":"crossref","first-page":"158","DOI":"10.7150\/ijbs.28392","article-title":"Exosomes derived from human induced pluripotent stem cells-endothelia cells promotes postnatal angiogenesis in mice bearing ischemic limbs","volume":"15","author":"Ye","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"18","key":"10.1016\/j.yjmcc.2023.12.009_bb0450","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.122.061736","article-title":"Combined treatment of human induced pluripotent stem cell-derived cardiomyocytes and endothelial cells regenerate the infarcted heart in mice and non-human primates","volume":"148","author":"Cheng","year":"2023","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.009_bb0455","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/ejhf.2772","article-title":"Effect of allogeneic adipose tissue-derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction - the SCIENCE trial","volume":"25","author":"Qayyum","year":"2023","journal-title":"Eur. J. Heart Fail."},{"issue":"9","key":"10.1016\/j.yjmcc.2023.12.009_bb0460","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2022.11.061","article-title":"Randomized trial of targeted transendocardial mesenchymal precursor cell therapy in patients with heart failure","volume":"81","author":"Perin","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"27","key":"10.1016\/j.yjmcc.2023.12.009_bb0465","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/eurheartj\/ehv136","article-title":"Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial)","volume":"36","author":"Mathiasen","year":"2015","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.12.009_bb0470","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/ejhf.1700","article-title":"Bone marrow-derived mesenchymal stromal cell treatment in patients with ischaemic heart failure: final 4-year follow-up of the MSC-HF trial","volume":"22","author":"Mathiasen","year":"2020","journal-title":"Eur. J. Heart Fail."},{"issue":"23","key":"10.1016\/j.yjmcc.2023.12.009_bb0475","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2013.02.071","article-title":"Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics","volume":"61","author":"Bartunek","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.yjmcc.2023.12.009_bb0480","first-page":"648","article-title":"Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial","volume":"38","author":"Bartunek","year":"2017","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.yjmcc.2023.12.009_bb0485","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/ejhf.898","article-title":"Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the congestive heart failure cardiopoietic regenerative therapy (CHART-1) study","volume":"19","author":"Teerlink","year":"2017","journal-title":"Eur. J. Heart Fail."},{"issue":"12","key":"10.1016\/j.yjmcc.2023.12.009_bb0490","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCRESAHA.118.312978","article-title":"Rationale and design of the CONCERT-HF trial (combination of mesenchymal and c-kit(+) cardiac stem cells as regenerative therapy for heart failure)","volume":"122","author":"Bolli","year":"2018","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.009_bb0495","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ejhf.2178","article-title":"A phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial","volume":"23","author":"Bolli","year":"2021","journal-title":"Eur. J. Heart Fail."},{"issue":"10036","key":"10.1016\/j.yjmcc.2023.12.009_bb0500","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/S0140-6736(16)30137-4","article-title":"Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial","volume":"387","author":"Patel","year":"2016","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.009_bb0505","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCRESAHA.119.314951","article-title":"Phase 3 DREAM-HF trial of mesenchymal precursor cells in chronic heart failure","volume":"125","author":"Borow","year":"2019","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.12.009_bb0510","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0735-1097(02)02961-3","article-title":"Electromechanical mapping versus positron emission tomography and single photon emission computed tomography for the detection of myocardial viability in patients with ischemic cardiomyopathy","volume":"41","author":"Wiggers","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.009_bb0515","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ejhf.2807","article-title":"Cell therapy for heart failure: lessons learned from science","volume":"25","author":"Sanz-Ruiz","year":"2023","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.12.009_bb0520","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.stemcr.2019.04.005","article-title":"Human embryonic stem cell-derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular tachyarrhythmias","volume":"12","author":"Romagnuolo","year":"2019","journal-title":"Stem Cell Rep."},{"issue":"10","key":"10.1016\/j.yjmcc.2023.12.009_bb0525","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.stemcr.2021.08.005","article-title":"Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes","volume":"16","author":"Nakamura","year":"2021","journal-title":"Stem Cell Reports"},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.009_bb0530","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.stem.2023.03.010","article-title":"Gene editing to prevent ventricular arrhythmias associated with cardiomyocyte cell therapy","volume":"30","author":"Marchiano","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.009_bb0535","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/CIRCRESAHA.114.300558","article-title":"Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes","volume":"114","author":"Yang","year":"2014","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.yjmcc.2023.12.009_bb0540","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1089\/scd.2014.0533","article-title":"Immaturity of human stem-cell-derived cardiomyocytes in culture: fatal flaw or soluble problem?","volume":"24","author":"Veerman","year":"2015","journal-title":"Stem Cells Dev."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.12.009_bb0545","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nmeth.2524","article-title":"Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes","volume":"10","author":"Nunes","year":"2013","journal-title":"Nat. Methods"},{"issue":"8","key":"10.1016\/j.yjmcc.2023.12.009_bb0550","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1161\/CIRCRESAHA.113.302021","article-title":"Unique metabolic features of stem cells, cardiomyocytes, and their progenitors","volume":"114","author":"Gaspar","year":"2014","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.yjmcc.2023.12.009_bb0555","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/CIRCRESAHA.118.313249","article-title":"Metabolic maturation of human pluripotent stem cell-derived cardiomyocytes by inhibition of HIF1\u03b1 and LDHA","volume":"123","author":"Hu","year":"2018","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.009_bb0560","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.stemcr.2018.01.039","article-title":"Contractile work contributes to maturation of energy metabolism in hiPSC-derived cardiomyocytes","volume":"10","author":"Ulmer","year":"2018","journal-title":"Stem Cell Reports"},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.009_bb0565","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.stem.2022.02.011","article-title":"PPARdelta activation induces metabolic and contractile maturation of human pluripotent stem cell-derived cardiomyocytes","volume":"29","author":"Wickramasinghe","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10.1016\/j.yjmcc.2023.12.009_bb0570","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.ymthe.2018.02.026","article-title":"Pluripotent stem cell-derived cardiomyocytes as a platform for cell therapy applications: progress and hurdles for clinical translation","volume":"26","author":"Oikonomopoulos","year":"2018","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.yjmcc.2023.12.009_bb0575","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.stemcr.2015.10.004","article-title":"Repair of ischemic injury by pluripotent stem cell based cell therapy without Teratoma through selective photosensitivity","volume":"5","author":"Cho","year":"2015","journal-title":"Stem Cell Reports"},{"issue":"9","key":"10.1016\/j.yjmcc.2023.12.009_bb0580","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/mt.2015.100","article-title":"An inducible caspase-9 suicide gene to improve the safety of therapy using human induced pluripotent stem cells","volume":"23","author":"Yagyu","year":"2015","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.yjmcc.2023.12.009_bb0585","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.stem.2015.04.005","article-title":"Efficient detection and purification of cell populations using synthetic MicroRNA switches","volume":"16","author":"Miki","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10.1016\/j.yjmcc.2023.12.009_bb0590","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142000","article-title":"Method for selective ablation of undifferentiated human pluripotent stem cell populations for cell-based therapies","volume":"6","author":"Chour","year":"2021","journal-title":"JCI Insight"},{"issue":"7350","key":"10.1016\/j.yjmcc.2023.12.009_bb0595","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature10135","article-title":"Immunogenicity of induced pluripotent stem cells","volume":"474","author":"Zhao","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.009_bb0600","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.stem.2011.01.012","article-title":"Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells","volume":"8","author":"Pearl","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"8","key":"10.1016\/j.yjmcc.2023.12.009_bb0605","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.3860","article-title":"HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells","volume":"35","author":"Gornalusse","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.009_bb0610","first-page":"557","article-title":"Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use","volume":"16","author":"Lazarus","year":"1995","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.12.009_bb0615","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCRESAHA.115.305227","article-title":"Empowering adult stem cells for myocardial regeneration V2.0: success in small steps","volume":"118","author":"Broughton","year":"2016","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.yjmcc.2023.12.009_bb0620","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.ymthe.2018.05.009","article-title":"Mesenchymal stem cell-based therapy for cardiovascular disease: progress and challenges","volume":"26","author":"Bagno","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0625","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejphar.2014.09.033","article-title":"Cytoprotective effect of melatonin against hypoxia\/serum deprivation-induced cell death of bone marrow mesenchymal stem cells in vitro","volume":"748","author":"Wang","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0630","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.lfs.2016.09.013","article-title":"Reactive oxygen species-mediated cardiac-reperfusion injury: mechanisms and therapies","volume":"165","author":"Bagheri","year":"2016","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.yjmcc.2023.12.009_bb0635","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41419-020-2664-0","article-title":"Induction of ASC pyroptosis requires gasdermin D or caspase-1\/11-dependent mediators and IFN\u03b2 from pyroptotic macrophages","volume":"11","author":"Zhang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0640","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13287-018-0844-y","article-title":"Characterization of the interaction between human decidua parietalis mesenchymal stem\/stromal cells and natural killer cells","volume":"9","author":"Abumaree","year":"2018","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"10.1016\/j.yjmcc.2023.12.009_bb0645","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.117.310712","volume":"121","author":"Bartolucci","year":"2017","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.009_bb0650","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.stem.2009.02.001","article-title":"Mesenchymal stem cell homing: the devil is in the details","volume":"4","author":"Karp","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0655","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.isci.2019.05.004","article-title":"Mesenchymal stromal cell homing: mechanisms and strategies for improvement","volume":"15","author":"Ullah","year":"2019","journal-title":"iScience"},{"issue":"13","key":"10.1016\/j.yjmcc.2023.12.009_bb0660","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.7150\/thno.24475","article-title":"CCR2-dependent monocytes\/macrophages exacerbate acute brain injury but promote functional recovery after ischemic stroke in mice","volume":"8","author":"Fang","year":"2018","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.yjmcc.2023.12.009_bb0665","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1161\/CIRCRESAHA.109.196030","article-title":"Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium","volume":"106","author":"Huang","year":"2010","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0670","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13287-017-0614-2","article-title":"Overexpression of c-met in bone marrow mesenchymal stem cells improves their effectiveness in homing and repair of acute liver failure","volume":"8","author":"Wang","year":"2017","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0675","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13287-018-0914-1","article-title":"Adipose-derived and bone marrow mesenchymal stem cells: a donor-matched comparison","volume":"9","author":"Mohamed-Ahmed","year":"2018","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0680","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s13287-022-03120-7","article-title":"Oct4 cooperates with c-Myc to improve mesenchymal-to-endothelial transition and myocardial repair of cardiac-resident mesenchymal stem cells","volume":"13","author":"Zhao","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.009_bb0685","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/CIRCRESAHA.119.314806","article-title":"Roles of the mesenchymal stromal\/stem cell marker Meflin in cardiac tissue repair and the development of diastolic dysfunction","volume":"125","author":"Hara","year":"2019","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0690","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s13287-021-02553-w","article-title":"Oct4-dependent FoxC1 activation improves the survival and neovascularization of mesenchymal stem cells under myocardial ischemia","volume":"12","author":"Ji","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.009_bb0695","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/cvr\/cvy207","article-title":"Y-27632 preconditioning enhances transplantation of human-induced pluripotent stem cell-derived cardiomyocytes in myocardial infarction mice","volume":"115","author":"Zhao","year":"2019","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.009_bb0700","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cvr\/cvz179","article-title":"N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts","volume":"116","author":"Lou","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0705","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/stem.3079","article-title":"Understanding and leveraging cell metabolism to enhance mesenchymal stem cell transplantation survival in tissue engineering and regenerative medicine applications","volume":"38","author":"Salazar-Noratto","year":"2020","journal-title":"Stem Cells (Dayton, Ohio)"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0710","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13287-016-0436-7","article-title":"Mesenchymal stem cells\/multipotent stromal cells (MSCs) are glycolytic and thus glucose is a limiting factor of in vitro models of MSC starvation","volume":"7","author":"Nuschke","year":"2016","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.009_bb0715","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/stem.2763","article-title":"Human mesenchymal stem cell failure to adapt to glucose shortage and rapidly use intracellular energy reserves through glycolysis explains poor cell survival after implantation","volume":"36","author":"Moya","year":"2018","journal-title":"Stem Cells (Dayton, Ohio)"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0720","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/ten.teb.2022.0063","article-title":"Glucose metabolism: optimizing regenerative functionalities of mesenchymal stromal cells postimplantation","volume":"29","author":"Luo","year":"2023","journal-title":"Tissue Eng. B Rev."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.009_bb0725","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/stem.1299","article-title":"Proangiogenic and prosurvival functions of glucose in human mesenchymal stem cells upon transplantation","volume":"31","author":"Deschepper","year":"2013","journal-title":"Stem Cells (Dayton, Ohio)"},{"issue":"5","key":"10.1016\/j.yjmcc.2023.12.009_bb0730","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41419-018-0579-9","article-title":"Leptin increases mitochondrial OPA1 via GSK3-mediated OMA1 ubiquitination to enhance therapeutic effects of mesenchymal stem cell transplantation","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0735","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s13287-022-03016-6","article-title":"Andrographolide protects bone marrow mesenchymal stem cells against glucose and serum deprivation under hypoxia via the NRF2 signaling pathway","volume":"13","author":"Sun","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.009_bb0740","doi-asserted-by":"crossref","DOI":"10.1063\/1.5000746","article-title":"Modelling ischemia-reperfusion injury (IRI) in vitro using metabolically matured induced pluripotent stem cell-derived cardiomyocytes","volume":"2","author":"Hidalgo","year":"2018","journal-title":"APL Bioeng."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0745","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13287-015-0057-6","article-title":"Susceptibility of murine induced pluripotent stem cell-derived cardiomyocytes to hypoxia and nutrient deprivation","volume":"6","author":"Brodarac","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0750","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ijbiomac.2018.11.115","article-title":"Studies on the effects of microencapsulated human mesenchymal stem cells in RGD-modified alginate on cardiomyocytes under oxidative stress conditions using in vitro biomimetic co-culture system","volume":"123","author":"Choe","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0755","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13287-022-02840-0","article-title":"PPAR\u03b2\/\u03b4 priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia-reperfusion injury","volume":"13","author":"Sarre","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.009_bb0760","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/btpr.2034","article-title":"Metabolic regulation of mesenchymal stem cell in expansion and therapeutic application","volume":"31","author":"Liu","year":"2015","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0765","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1475-2840-12-40","article-title":"Impaired cardioprotective function of transplantation of mesenchymal stem cells from patients with diabetes mellitus to rats with experimentally induced myocardial infarction","volume":"12","author":"Liu","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.009_bb0770","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/cvr\/cvaa118","article-title":"Ex vivo Ikk\u03b2 ablation rescues the immunopotency of mesenchymal stromal cells from diabetics with advanced atherosclerosis","volume":"117","author":"Kizilay Mancini","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.yjmcc.2023.12.009_bb0775","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00395-018-0703-0","article-title":"Cardiac mesenchymal cells from diabetic mice are ineffective for cell therapy-mediated myocardial repair","volume":"113","author":"Mehra","year":"2018","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0780","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.freeradbiomed.2018.11.003","article-title":"17\u03b2-estradiol protects mesenchymal stem cells against high glucose-induced mitochondrial oxidants production via Nrf2\/Sirt3\/MnSOD signaling","volume":"130","author":"Oh","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"10","key":"10.1016\/j.yjmcc.2023.12.009_bb0785","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ. Res."},{"issue":"17","key":"10.1016\/j.yjmcc.2023.12.009_bb0790","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1161\/CIRCULATIONAHA.108.780999","article-title":"Metabolic management of acute myocardial infarction comes to the fore and extends beyond control of hyperglycemia","volume":"117","author":"Opie","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0795","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.intimp.2018.12.063","article-title":"Effects of palmitate and astaxanthin on cell viability and proinflammatory characteristics of mesenchymal stem cells","volume":"68","author":"Yaghooti","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.009_bb0800","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ymthe.2017.12.013","article-title":"IFN-\u03b3 and TNF-\u03b1 pre-licensing protects mesenchymal stromal cells from the pro-inflammatory effects of palmitate","volume":"26","author":"Boland","year":"2018","journal-title":"Mol. Ther."},{"issue":"9","key":"10.1016\/j.yjmcc.2023.12.009_bb0805","doi-asserted-by":"crossref","DOI":"10.3390\/cells8091095","article-title":"Fatty acid-treated induced pluripotent stem cell-derived human cardiomyocytes exhibit adult cardiomyocyte-like energy metabolism phenotypes","volume":"8","author":"Horikoshi","year":"2019","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.yjmcc.2023.12.009_bb0810","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41422-020-0292-y","article-title":"The cell surface marker CD36 selectively identifies matured, mitochondria-rich hPSC-cardiomyocytes","volume":"30","author":"Poon","year":"2020","journal-title":"Cell Res."},{"issue":"10","key":"10.1016\/j.yjmcc.2023.12.009_bb0815","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/stcltm\/szac061","article-title":"Metabolic maturation increases susceptibility to hypoxia-induced damage in human iPSC-derived cardiomyocytes","volume":"11","author":"Peters","year":"2022","journal-title":"Stem Cells Transl. Med."},{"issue":"6514","key":"10.1016\/j.yjmcc.2023.12.009_bb0820","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1126\/science.abc8861","article-title":"Comprehensive quantification of fuel use by the failing and nonfailing human heart","volume":"vol. 370","author":"Murashige","year":"2020","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0825","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12933-023-01958-6","article-title":"Serum branch-chained amino acids are increased in type 2 diabetes and associated with atherosclerotic cardiovascular disease","volume":"22","author":"Moreno-Vedia","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.009_bb0830","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cmet.2016.11.005","article-title":"Defective branched-chain amino acid catabolism disrupts glucose metabolism and sensitizes the heart to ischemia-reperfusion injury","volume":"25","author":"Li","year":"2017","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.yjmcc.2023.12.009_bb0835","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.7150\/thno.44836","article-title":"Branched chain amino acids exacerbate myocardial ischemia\/reperfusion vulnerability via enhancing GCN2\/ATF6\/PPAR-\u03b1 pathway-dependent fatty acid oxidation","volume":"10","author":"Li","year":"2020","journal-title":"Theranostics"},{"issue":"21","key":"10.1016\/j.yjmcc.2023.12.009_bb0840","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.115.020226","article-title":"Catabolic defect of branched-chain amino acids promotes heart failure","volume":"133","author":"Sun","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0845","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41392-022-00971-7","article-title":"Excessive branched-chain amino acid accumulation restricts mesenchymal stem cell-based therapy efficacy in myocardial infarction","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"13","key":"10.1016\/j.yjmcc.2023.12.009_bb0850","first-page":"e2206439","article-title":"Suppressing Mesenchymal stromal cell ferroptosis via targeting a metabolism-epigenetics axis corrects their poor retention and insufficient healing benefits in the injured liver Milieu","volume":"vol. 10","author":"Hu","year":"2023","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0855","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.yjmcc.2020.10.014","article-title":"DCA-TGR5 signaling activation alleviates inflammatory response and improves cardiac function in myocardial infarction","volume":"151","author":"Wang","year":"2021","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0860","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jconrel.2020.09.023","article-title":"Bile acid-based dual-functional prodrug nanoparticles for bone regeneration through hydrogen peroxide scavenging and osteogenic differentiation of mesenchymal stem cells","volume":"328","author":"Arai","year":"2020","journal-title":"J. Controll. Release"},{"key":"10.1016\/j.yjmcc.2023.12.009_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101144","article-title":"TUDCA-treated chronic kidney disease-derived hMSCs improve therapeutic efficacy in ischemic disease via PrP(C)","volume":"22","author":"Yoon","year":"2019","journal-title":"Redox Biol."},{"issue":"11","key":"10.1016\/j.yjmcc.2023.12.009_bb0870","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/CIRCRESAHA.122.320488","article-title":"Histone Lactylation boosts reparative gene activation post-myocardial infarction","volume":"131","author":"Wang","year":"2022","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0875","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/jcb.24357","article-title":"Macrophages modulate the viability and growth of human mesenchymal stem cells","volume":"114","author":"Freytes","year":"2013","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.009_bb0880","first-page":"2003348","article-title":"Surface-anchored nanogel coating endows stem cells with stress resistance and reparative potency via turning down the Cytokine-receptor binding pathways","volume":"vol. 8","author":"Zhang","year":"2021","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"23","key":"10.1016\/j.yjmcc.2023.12.009_bb0885","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1161\/CIRCULATIONAHA.116.023527","article-title":"Left ventricular dysfunction switches mesenchymal stromal cells toward an inflammatory phenotype and impairs their reparative properties via toll-like receptor-4","volume":"135","author":"Naftali-Shani","year":"2017","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.yjmcc.2023.12.009_bb0890","article-title":"Designing hydrogels for controlled drug delivery, nature reviews","volume":"1","author":"Li","year":"2016","journal-title":"Materials"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0895","article-title":"Injectable hydrogels for improving cardiac cell therapy-in vivo evidence and translational challenges","volume":"vol. 7","author":"Hoeeg","year":"2021","journal-title":"Gels (Basel, Switzerland)"},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.009_bb0900","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1021\/acsami.2c16682","article-title":"Injectable decellularized extracellular matrix hydrogel containing stromal cell-derived factor 1 promotes transplanted cardiomyocyte engraftment and functional regeneration after myocardial infarction","volume":"15","author":"Wu","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"39","key":"10.1016\/j.yjmcc.2023.12.009_bb0905","doi-asserted-by":"crossref","first-page":"33088","DOI":"10.1021\/acsami.8b13571","article-title":"Cardiac stem cell patch integrated with microengineered blood vessels promotes cardiomyocyte proliferation and neovascularization after acute myocardial infarction","volume":"10","author":"Su","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"538","key":"10.1016\/j.yjmcc.2023.12.009_bb0910","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat9683","article-title":"An off-the-shelf artificial cardiac patch improves cardiac repair after myocardial infarction in rats and pigs","volume":"12","author":"Huang","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.yjmcc.2023.12.009_bb0915","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41551-021-00796-9","article-title":"Injectable and conductive cardiac patches repair infarcted myocardium in rats and minipigs","volume":"5","author":"Wang","year":"2021","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0920","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s40824-022-00319-w","article-title":"Stem cell laden nano and micro collagen\/PLGA bimodal fibrous patches for myocardial regeneration","volume":"26","author":"Wee","year":"2022","journal-title":"Biomater. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0925","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12951-023-02063-2","article-title":"Application of biomedical materials in the diagnosis and treatment of myocardial infarction","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"9","key":"10.1016\/j.yjmcc.2023.12.009_bb0930","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202104079","article-title":"Engineered magnetic nanocomposites to modulate cellular function","volume":"18","author":"Filippi","year":"2022","journal-title":"Small"},{"issue":"31","key":"10.1016\/j.yjmcc.2023.12.009_bb0935","doi-asserted-by":"crossref","first-page":"eadf2898","DOI":"10.1126\/sciadv.adf2898","article-title":"Nanowired human cardiac organoid transplantation enables highly efficient and effective recovery of infarcted hearts","volume":"9","author":"Tan","year":"2023","journal-title":"Sci. Adv."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.12.009_bb0940","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41587-019-0197-9","article-title":"Epicardial cells derived from human embryonic stem cells augment cardiomyocyte-driven heart regeneration","volume":"37","author":"Bargehr","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.yjmcc.2023.12.009_bb0945","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.stem.2014.11.009","article-title":"Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells","volume":"15","author":"Ye","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.009_bb0950","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/cvr\/cvad004","article-title":"Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice","volume":"119","author":"Lou","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.009_bb0955","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0003-4975(02)03591-9","article-title":"Xenotransplant cardiac chimera: immune tolerance of adult stem cells","volume":"74","author":"Saito","year":"2002","journal-title":"Ann. Thorac. Surg."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.12.009_bb0960","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/CIRCRESAHA.117.311648","article-title":"S1P-S1PR2 axis mediates homing of muse cells into damaged heart for long-lasting tissue repair and functional recovery after acute myocardial infarction","volume":"122","author":"Yamada","year":"2018","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.yjmcc.2023.12.009_bb0965","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/sctm.19-0013","article-title":"Optimization of timing and times for administration of atorvastatin-pretreated mesenchymal stem cells in a preclinical model of acute myocardial infarction","volume":"8","author":"Xu","year":"2019","journal-title":"Stem Cells Transl. Med."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.12.009_bb0970","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/1574888X16666210816111031","article-title":"Efficacy and safety of mesenchymal stem cell therapy in patients with acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials","volume":"17","author":"Yu","year":"2022","journal-title":"Curr. Stem Cell Res. Ther."},{"issue":"10","key":"10.1016\/j.yjmcc.2023.12.009_bb0975","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.ymthe.2020.06.026","article-title":"Adiponectin stimulates exosome release to enhance mesenchymal stem-cell-driven therapy of heart failure in mice","volume":"28","author":"Nakamura","year":"2020","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.009_bb0980","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007400","article-title":"Repeated administrations of cardiac progenitor cells are superior to a single Administration of an Equivalent Cumulative Dose","volume":"7","author":"Tang","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.009_bb0985","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.gendis.2022.09.001","article-title":"Engineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site","volume":"10","author":"Schwartz","year":"2023","journal-title":"Genes Dis."},{"issue":"7","key":"10.1016\/j.yjmcc.2023.12.009_bb0990","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/s41551-021-00815-9","article-title":"Genetically engineered and enucleated human mesenchymal stromal cells for the targeted delivery of therapeutics to diseased tissue","volume":"6","author":"Wang","year":"2022","journal-title":"Nat. Biomed. Eng."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282823002134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282823002134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:01:38Z","timestamp":1762668098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282823002134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":198,"alternative-id":["S0022282823002134"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2023.12.009","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem cell-based therapy in cardiac repair after myocardial infarction: Promise, challenges, and future directions","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2023.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}